title: The role of heart-type fatty acid-binding protein in predicting properties of coronary atherosclerosis in patients with acute coronary syndrome.
abstract: BACKGROUND
  Fatty acid-binding protein (FABP) is an independent predictor of cardiac events. However, the relation between increasing FABP and coronary atherosclerosis is unknown. We have investigated the relation between FABP and angiographic properties of coronary atherosclerosis in patients with acute coronary syndrome (ACS).
  
  
  METHODS
  The study population consisted of 93 patients with ACS (mean age: 56±10 years). Patients presenting to the emergency department within 2 h after onset of anginal symptoms were enrolled in the study. FABP was measured at second, fourth and sixth hours of chest pain. Cut-off FABP was accepted as 1.9 ng/ml. Coronary atherosclerosis was assessed with diseased vessel number (≥50 and ≥70% luminal narrowing), Gensini and extent scores.
  
  
  RESULTS
  Median FABP-2 was 2.9 ng/ml (interquartile range: 1.6-10.4). Peak FABP was measured at fourth hour [median: 35.0 ng/ml (interquartile range: 2-77)]. There was a nonsignificant relation between angiographic findings and FABP-2. At fourth hour, Gensini, extent score and diseased vessel number were significantly higher above the cut-off level of FABP-4 (Gensini score: 3.7±3.4 vs. 6.2±3.4, P=0.005; extent score: 11.1±10 vs. 22.3±19.2, P=0.007; diseased vessel: 0.7±0.6 vs. 1.6±1.0, P=0.003, respectively). The sensitivity of FABP-2 for at least 50% lesion was 70%. The highest sensitivity was obtained at fourth hour (85% for ≥50% and 88% for ≥70% lesions). The sensitivity and positive predictive values for revascularization were 70 and 77% for FABP-2, 89 and 80% for FABP-4 and 89 and 81% for FABP-6.
  
  
  CONCLUSIONS
  FABP levels are closely related with angiographic properties of patients with ACS. FABP may be an early and important marker for predicting the coronary anatomy and decision of treatment.
authors.affiliation: Department of Cardiology, Erciyes University, Kayseri, Turkey. nihatkalay@hotmail.com
authors.forename: Nihat
authors.initials: N
authors.lastname: Kalay
authors.forename: Mikail
authors.initials: M
authors.lastname: Yarlioglues
authors.forename: Idris
authors.initials: I
authors.lastname: Ardic
authors.forename: Mehmet Gungor
authors.initials: MG
authors.lastname: Kaya
authors.forename: Alper
authors.initials: A
authors.lastname: Vardar
authors.forename: Tugrul
authors.initials: T
authors.lastname: Inanc
authors.forename: Ali
authors.initials: A
authors.lastname: Dogan
authors.forename: Ibrahim
authors.initials: I
authors.lastname: Ikizceli
authors.forename: Fatih
authors.initials: F
authors.lastname: Koç
authors.forename: Abdurrahman
authors.initials: A
authors.lastname: Oguzhan
authors.forename: Ali
authors.initials: A
authors.lastname: Ergin
mesh_terms: D054058:Acute Coronary Syndrome / Q000097:blood* / Q000000981:diagnostic imaging / Q000209:etiology / Q000503:physiopathology; D000368:Aged; D015415:Biomarkers / Q000097:blood; D002637:Chest Pain / Q000175:diagnosis; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000097:blood* / Q000150:complications / Q000000981:diagnostic imaging; D004311:Double-Blind Method; D042241:Early Diagnosis; D050556:Fatty Acid-Binding Proteins / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011446:Prospective Studies; D013997:Time Factors; D014421:Turkey
chemical_list: D015415:Biomarkers; D050556:Fatty Acid-Binding Proteins